Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
250
Value
$420
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PACB by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026250$420<0.1%−53−17.5%ReducedHolders
Q1 2026303$400<0.1%00.0%UnchangedHolders
Q4 2025303$567<0.1%00.0%UnchangedHolders
Q3 2025303$388<0.1%+7+2.4%AddedHolders
Q2 2025296$367<0.1%+57+23.8%AddedHolders
Q1 2025239$282<0.1%−525−68.7%ReducedHolders
Q4 2024764$1.40K<0.1%−733−49.0%ReducedHolders
Q3 20241,497$2.54K<0.1%−1,510−50.2%ReducedHolders
Q2 20243,007$4.12K<0.1%+84+2.9%AddedHolders
Q1 20242,923$11.0K<0.1%−57,777−95.2%ReducedHolders
Q4 202360,700$595.5K<0.1%+41,816+221.4%AddedHolders
Q3 202318,884$157.7K<0.1%−1,381−6.8%ReducedHolders
Q2 202320,265$269.5K<0.1%+16,127+389.7%AddedHolders
Q1 20234,138$47.9K<0.1%−195−4.5%ReducedHolders
Q4 20224,333$35.4K<0.1%+1,036+31.4%AddedHolders
Q3 20223,297$19.0K<0.1%−231−6.5%ReducedHolders
Q2 20223,528$16.0K<0.1%−22,233−86.3%ReducedHolders
Q1 202225,761$234.0K<0.1%+2,469+10.6%AddedHolders
Q4 202123,292$477.0K<0.1%+4,462+23.7%AddedHolders
Q3 202118,830$482.0K<0.1%+2,778+17.3%AddedHolders
Q2 202116,052$561.0K<0.1%+1,307+8.9%AddedHolders
Q1 202114,745$491.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.